CCAB Partners With ImmunoBiochem as it Launches New Co-Development Strategy to Advance Early-Stage Biotech Companies Read more
Cancer Prevention Pharmaceuticals Completes North American Licensing Deal with Mallinckrodt Read more
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company Read more